This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)
The safety profile of drotrecogin alfa (activated)
-
* Corresponding author: Roberto Fumagalli roberto.fumagalli@unimib.it
Critical Care 2007, 11(Suppl 5):S6 doi:10.1186/cc6157
Accesses
- Last 30 days: 38 accesses
- Last year: 431 accesses
- All time: 3632 accesses
Cited by
BioMed Central: 2 citations
|
Recombinant human activated protein C: current insights into its mechanism of action Marcel Levi, Tom van der Poll Critical Care 2007, 11(Suppl 5):S3 (19 December 2007) |
|
Introduction: severe sepsis and drotrecogin alfa (activated) Antonio Artigas, Claude D Martin Critical Care 2007, 11(Suppl 5):S1 (19 December 2007) |